To explore the characteristics of immune cell infiltration in clinical samples, we collected PBMCs from 5 AML patients and 5 healthy donors to detect the proportion of CD4+T cells, CD8+T cells, B cells and CD56+ NK cells. The gene discussed is NCAM1; the disease is acute myeloid leukemia.